El mercado mundial de fabricación de células madre se valoró en 12,58 mil millones en 2022 y se proyecta que alcance los 21,57 mil millones para 2029, creciendo a una CAGR del 9,4% entre 2022 y 2029.
El desarrollo de diversos tipos de fármacos , así como el estudio de los efectos químicos de los fármacos en diferentes células y tejidos y la determinación de si estos fármacos pueden reparar o reemplazar células o tejidos dañados, se realizan mediante el uso de células madre, que se obtienen a partir de células sanguíneas o fragmentos de médula ósea. Este es un mercado que actualmente está surgiendo y es tendencia.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2022-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (miles de millones de USD) |
| Segmentación | Por producto, por aplicación, por usuario final y por región. |
| Por producto |
|
| Por aplicación |
|
| Por el usuario final |
|
| Por región |
|
Las células madre son esenciales para el tratamiento de enfermedades, así como para proyectos de investigación especializados como las pruebas genéticas y la terapia personalizada. Los interesados públicos y corporativos financian cada vez más el desarrollo de tecnología basada en células madre a medida que son más conscientes del potencial terapéutico de las células madre y de la escasez de tratamientos efectivos para enfermedades raras.
El aumento de la población anciana y la creciente incidencia del cáncer tendrán un impacto significativo en el desarrollo de la industria de fabricación de células madre . Los factores que impulsan la expansión del mercado de fabricación de células madre incluyen, además de esto, el aumento de la urbanización y el ingreso personal disponible. Además, el aumento del gasto en infraestructura sanitaria es uno de los factores clave de la industria que impulsaría aún más el mercado de fabricación de células madre. Además, el ritmo de crecimiento del mercado se verá atenuado por la creciente conciencia pública sobre la eficacia terapéutica de los productos de células madre.
The global Stem Cell Manufacturing market was valued at 12.58 billion in 2022 and is projected to reach 21.57 billion by 2029, growing at a CAGR of 9.4% from 2022 to 2029
Based on product, application, end-user, and region the stem cell manufacturing market report's divisions are broken down.
The global Stem Cell Manufacturing market registered a CAGR of 9.4% from 2022 to 2029. The industry segment was the highest revenue contributor to the market.
Key players profiled in the report include Thermo Fisher Scientific, Merck Millipore, Lonza Group AG, Danaher Corporation, Sartorius AG, Bio-Rad Laboratories, Becton, Dickinson and Company, Stemcell Technologies, Fujifilm Holdings Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Bio-Techne Corporation, Takara Bio Group, Eppendorf AG, Getinge, Himedia Laboratories, Anterogen, Cellgenix GMBH, and Promocell.
The stem cell manufacturing market was dominated by North America in 2020, followed by Europe. The development of the stem cell manufacturing market in North America is also supported by elements like the region's strong research infrastructure, growing public awareness regarding the therapeutic potential of stem cells in efficient disease management, and rising adoption of novel stem cell therapies in the US.
Based on product, application, end user and region, the global market for professional Stem Cell Manufacturing is divided into these categories.
Consumables, instruments, and stem cell lines make up the market segments for stem cell manufacturing according to the product. The market for stem cell production has a section called stem cell lines that is expanding at the quickest rate. The demand for functionally potent stem cell lines in research, the increasing acceptance of stem cell-based medicinal products in the US, Europe, and Asia, and the development of novel stem cell culture & preservation techniques are the primary drivers of market expansion.
In terms of application, the clinical applications sector held the second-largest market share for stem cell production in 2020.
The stem cell manufacturing market is divided into three application categories based on use: research, clinical, and cell & tissue banking. The growing understanding of stem cells' therapeutic potential in the management of effective disease, technological developments in genome-based cell analysis and other stem cell manufacturing techniques and improving infrastructure for stem cell processing and preservation are the main drivers of the demand for stem cell-based products in clinical applications.
In terms of end users, pharmaceutical and biotechnology firms held the greatest market share for stem cell production in 2020.
The pharmaceutical and biotechnology industries, academic institutions, research laboratories, and contract research organizations, hospitals and surgical centers, cell banks and tissue banks, and other end users are the market segments for stem cell manufacturing based on end users. In 2020, the pharmaceutical and biotechnology industries predominated. Major end customers of stem cell products include pharmaceutical and biotechnology firms. For internal clinical research and medication discovery activities, these goods are used. Stem cell-based research is receiving more private funding, which is what is essentially driving the demand for stem cell products among pharma-biotech businesses.
[caption id="attachment_16526" align="aligncenter" width="1920"]
The major players operating in the global Stem Cell Manufacturing industry include the major market players include Thermo Fisher Scientific, Merck Millipore, Lonza Group AG, Danaher Corporation, Sartorius AG, Bio-Rad Laboratories, Becton, Dickinson and Company, Stemcell Technologies, Fujifilm Holdings Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Bio-Techne Corporation, Takara Bio Group, Eppendorf AG, Getinge, Himedia Laboratories, Anterogen, Cellgenix GMBH, and Promocell.
Industry Development
20 April 2022: The PPD clinical research business of Thermo Fisher Scientific Inc. and Matrix Clinical Trials, a Matrix Medical Network offering, are collaborating to bring clinical trials to patients with an innovative decentralized clinical trial (DCT) solution. 23 January 2023: Two global leaders are joining strengths in a broad new effort to advance the discovery and innovation needed to address complex scientific challenges. The University of California San Diego and Thermo Fisher Scientific have agreed to form a transformational 10-year strategic partnership that leverages the leading expertise of each organization.Geographically, the Stem Cell Manufacturing market is segmented into North America, South America, Europe, APAC, and MEA.
The stem cell manufacturing market was dominated by North America in 2020, followed by Europe. The development of the stem cell manufacturing market in North America is also supported by elements like the region's strong research infrastructure, growing public awareness regarding the therapeutic potential of stem cells in efficient disease management, and rising adoption of novel stem cell therapies in the US. However, this industry is being constrained by strict rules governing ESCs and iPSC-based clinical research as well as fierce market competition from other therapeutic technologies (including gene therapy, drug-based treatment, and tissue and organ transplantation).
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.